Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV No short position is open on this share today.
Follow
0.00% of the capital sold short
0 disclosing funds
689 disclosures on record
Evolution of the disclosed total 0% 1% 2% 3%
2025-13-01 Apr 2026 Jul 2026 Oct 2026
Sum of open short positions, as % of capital. Hover or tap the curve to see which funds make it up. Over the whole history, the total peaked at 5.00% on May 21, 2018. The shaded band matches the twelve months of the first chart. July 31, 2015 today
Open positions No fund discloses a short position on this share today. The History of disclosures table lists the ones that existed.
Follow by RSS
Get the moves on Lakefront Biotherapeutics NV by mail, at most once a day.
There is no account to create. You give an address, you confirm it through a link, and every message contains a link to stop.
History of disclosures 689 disclosures on record for this share. Date Fund % of capital End of publication July 17, 2019 Marshall Wace LLP 0.69% July 15, 2019 Marshall Wace LLP 0.71% July 4, 2019 Citadel Advisors LLC 0.49% July 2, 2019 Citadel Advisors LLC 0.56% June 27, 2019 Marshall Wace LLP 1.00% June 21, 2019 Citadel Advisors LLC 0.68% June 19, 2019 Marshall Wace LLP 0.97% June 17, 2019 Citadel Advisors LLC 0.79% June 13, 2019 Citadel Advisors LLC 0.80% June 11, 2019 Marshall Wace LLP 0.80% June 11, 2019 Citadel Advisors LLC 0.79% June 10, 2019 AQR Capital Management, LLC 1.98% June 7, 2019 Citadel Advisors LLC 0.80% June 7, 2019 Marshall Wace LLP 0.71% June 3, 2019 AQR Capital Management, LLC 2.00% May 31, 2019 Marshall Wace LLP 0.60% May 20, 2019 Marshall Wace LLP 0.51% May 15, 2019 AQR Capital Management, LLC 1.92% May 15, 2019 Citadel Advisors LLC 0.79% April 25, 2019 AQR Capital Management, LLC 1.80% April 17, 2019 Citadel Advisors LLC 0.82% April 15, 2019 AQR Capital Management, LLC 1.76% April 8, 2019 AQR Capital Management, LLC 1.69% April 5, 2019 Citadel Advisors LLC 0.78% April 3, 2019 Citadel Advisors LLC 0.80% March 29, 2019 Citadel Advisors LLC 0.76% February 22, 2019 AQR Capital Management, LLC 1.70% February 21, 2019 AQR Capital Management, LLC 1.69% February 20, 2019 AQR Capital Management, LLC 1.70% January 11, 2019 AQR Capital Management, LLC 1.69% January 10, 2019 AQR Capital Management, LLC 1.70% January 9, 2019 AQR Capital Management, LLC 1.69% January 8, 2019 AQR Capital Management, LLC 1.70% November 30, 2018 AQR Capital Management, LLC 1.68% November 13, 2018 Balyasny Asset Management LP 0.47% November 12, 2018 Balyasny Asset Management LP 0.51% October 2, 2018 AQR Capital Management, LLC 1.79% September 18, 2018 AQR Capital Management, LLC 1.85% September 17, 2018 AQR Capital Management, LLC 1.92% September 13, 2018 AQR Capital Management, LLC 2.03% September 11, 2018 AQR Capital Management, LLC 2.10% September 7, 2018 AQR Capital Management, LLC 2.09% August 31, 2018 AQR Capital Management, LLC 2.16% August 16, 2018 Marshall Wace LLP 0.46% August 15, 2018 AQR Capital Management, LLC 2.29% July 30, 2018 WorldQuant, LLC 0.47% July 26, 2018 Marshall Wace LLP 0.52% July 20, 2018 AQR Capital Management, LLC 2.39% July 19, 2018 Marshall Wace LLP 0.37% July 17, 2018 Marshall Wace LLP 0.50%
Download 689 filings as CSV Columns: Date, Fund, Market, Disclosed position, Unit, End date. The other formats
Page 9 of 14
Other companies sold short in the Netherlands Cite this page The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=9